These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 321989)

  • 1. [Combination of antimetabolites and alkylating agents in the treatment of advanced breast cancer].
    Germiniani R; Pipino G; Lavorato F; Bressani Doldi S
    Minerva Med; 1977 Mar; 68(13):831-4. PubMed ID: 321989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination antimetabolite-alkylating agent-vinblastine in the treatment of advanced breast cancer].
    Pipino G; Germiniani R; Lavorato F
    Minerva Med; 1977 Mar; 68(13):835-7. PubMed ID: 321990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of advanced breast cancer with alkylating agents].
    Pipino G; Germiniani R; Lavorato F; Tajana A
    Minerva Med; 1977 Mar; 68(13):823-30. PubMed ID: 403484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of metastatic breast cancer with adriamycin-cyclophosphamide induction followed by alternating combination therapy.
    Abeloff MD; Ettinger DS
    Cancer Treat Rep; 1977 Dec; 61(9):1685-9. PubMed ID: 340033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
    Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
    Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.
    Mouridsen HT; Palshof T; Brahm M; Rahbek I
    Cancer Treat Rep; 1977; 61(1):47-50. PubMed ID: 324620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy of breast cancer.
    Hall TC
    Clin Obstet Gynecol; 1968 Jun; 11(2):401-15. PubMed ID: 4972174
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy for breast cancer.
    Sarg MJ
    J Reprod Med; 1979 Jul; 23(1):3-11. PubMed ID: 226698
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination chemotherapy in metastatic breast cancer].
    Kuten A; Lev L; Mohaliver J; Robinson E
    Harefuah; 1981 Feb; 100(3):118-20. PubMed ID: 7262675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Marcrae KD
    Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779
    [No Abstract]   [Full Text] [Related]  

  • 12. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
    Frederiksen PL; Joergensen ST; Roesdahl K; Thomsen J; Mouridsen HT
    Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical controlled trial in advanced breast cancer: CMFV (cyclophosphamide, methotrexate, fluorouracil, vincristine) verus CD (carminomycin, dibromodulcitol).
    Neoplasma; 1982; 29(6):741-7. PubMed ID: 6761595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of 5-fluorouracil, methotrexate, cyclophosphamide and prednisone combination therapy in the treatment of advanced breast cancer].
    García Puche JL; Ballesteros P; Cueto J; Mendiola C; Rodríguez PA; Talavera MC
    Rev Clin Esp; 1979 Feb; 152(3):203-8. PubMed ID: 441472
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both].
    Clavel B; Cappelaere JP; Guerin J; Klein T; Pommatau E; Berlie J
    Sem Hop; 1982 Sep; 58(34):1919-23. PubMed ID: 6293073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of advanced breast cancer--actual results ].
    Matthes ML; Lenk H; Gürtler R; Tanneberger S
    Arch Geschwulstforsch; 1982 May; 52(3):241-6. PubMed ID: 6812538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of metastasizing breast cancer in general practice].
    Brunner KW
    Schweiz Med Wochenschr; 1973 Oct; 103(41):1406-13. PubMed ID: 4751561
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of advanced breast cancer with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone (CMFP)].
    Rabinovich MG; Leone BA; Landó O
    Medicina (B Aires); 1981; 41(1):65-70. PubMed ID: 7266359
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug therapy of cervical cancer].
    Dekster LI
    Vopr Onkol; 1974; 20(8):94-102. PubMed ID: 4215223
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.